Skip to main content
. 2021 Sep 30;25(2):296–301. doi: 10.1038/s41391-021-00456-8

Table 3.

Performance of the EPI test with a cut point of 15.6 in the pooled cohort.

EPI ≥ cut point EPI < cut point Total Performance (95%CI)
Biopsy positive/≥GG2 338 28 366 Sensitivity, 92.3% (89.1–94.9)
Biopsy negative/GG1 591 255 846 Specificity, 30.1% (27.1–33.4)
Total 929 283 1212 PPV, 36.4% (33.3–39.6)
NPV, 90.1% (86.0–93.3)
Prevalence 30.2% Predicted negative 23.3%